Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease
Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD.
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB194-AB194 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | AB194 |
---|---|
container_issue | 2 |
container_start_page | AB194 |
container_title | Journal of allergy and clinical immunology |
container_volume | 139 |
creator | Eastman, Jacqueline J., MD Cavagnero, Kellen J., B.S Deconde, Adam S., MD Kim, Alexander S., MD Broide, David H., MB, ChB, FAAAAI Zuraw, Bruce L., MD White, Andrew A., MD, FAAAAI Christiansen, Sandra C., MD, FAAAAI Doherty, Taylor Alan, MD, FAAAAI |
description | Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD. |
doi_str_mv | 10.1016/j.jaci.2016.12.631 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1867958862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674916321492</els_id><sourcerecordid>4313584041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1792-60460021c713898d08b1fc7757af60eecd156d53ec5cdfba3324f03494b0d70a3</originalsourceid><addsrcrecordid>eNp9UU1r3DAQFaWFbtP-gZ4EPdvVSLZkQwgsm00aWBroB_QmZGmcyPXajmSX7r-vzBYKOfQ0X-_NPN4Q8h5YDgzkxy7vjPU5T3kOPJcCXpANsFplsuLlS7JhrIZMqqJ-Td7E2LFUi6rekPDZRNPT2zAuE-X0bhjMjPRwOk6Po3d0h30f6dba5bj068QtwQ8PdHf_I4OEfvSNn_04UD_QbZx8GmZ0_9tYDE2CO_oF166Zx3Ci1z6iifiWvGpNH_Hd33hBvt_sv-0-ZYf727vd9pBZUDXPJCskYxysgqS0cqxqoLVKlcq0kiFaB6V0pUBbWtc2RghetEwUddEwp5gRF-TDee8UxqcF46y7cQlDOqmhkqouq0ryhOJnlA1jjAFbPQV_NOGkgenVW93p1Vu9equB6-RtIl2eSZj0__IYdLQeB4vOB7SzdqP_P_3qGd32fvDW9D_xhPGfTB25Zvrr-rz1dyAFh6Lm4g9v-ZZs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867958862</pqid></control><display><type>article</type><title>Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Eastman, Jacqueline J., MD ; Cavagnero, Kellen J., B.S ; Deconde, Adam S., MD ; Kim, Alexander S., MD ; Broide, David H., MB, ChB, FAAAAI ; Zuraw, Bruce L., MD ; White, Andrew A., MD, FAAAAI ; Christiansen, Sandra C., MD, FAAAAI ; Doherty, Taylor Alan, MD, FAAAAI</creator><creatorcontrib>Eastman, Jacqueline J., MD ; Cavagnero, Kellen J., B.S ; Deconde, Adam S., MD ; Kim, Alexander S., MD ; Broide, David H., MB, ChB, FAAAAI ; Zuraw, Bruce L., MD ; White, Andrew A., MD, FAAAAI ; Christiansen, Sandra C., MD, FAAAAI ; Doherty, Taylor Alan, MD, FAAAAI</creatorcontrib><description>Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2016.12.631</identifier><language>eng</language><publisher>St. Louis: Elsevier Inc</publisher><subject>Allergy and Immunology ; Respiratory diseases ; T cell receptors</subject><ispartof>Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB194-AB194</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Feb 01, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2016.12.631$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids></links><search><creatorcontrib>Eastman, Jacqueline J., MD</creatorcontrib><creatorcontrib>Cavagnero, Kellen J., B.S</creatorcontrib><creatorcontrib>Deconde, Adam S., MD</creatorcontrib><creatorcontrib>Kim, Alexander S., MD</creatorcontrib><creatorcontrib>Broide, David H., MB, ChB, FAAAAI</creatorcontrib><creatorcontrib>Zuraw, Bruce L., MD</creatorcontrib><creatorcontrib>White, Andrew A., MD, FAAAAI</creatorcontrib><creatorcontrib>Christiansen, Sandra C., MD, FAAAAI</creatorcontrib><creatorcontrib>Doherty, Taylor Alan, MD, FAAAAI</creatorcontrib><title>Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease</title><title>Journal of allergy and clinical immunology</title><description>Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD.</description><subject>Allergy and Immunology</subject><subject>Respiratory diseases</subject><subject>T cell receptors</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9UU1r3DAQFaWFbtP-gZ4EPdvVSLZkQwgsm00aWBroB_QmZGmcyPXajmSX7r-vzBYKOfQ0X-_NPN4Q8h5YDgzkxy7vjPU5T3kOPJcCXpANsFplsuLlS7JhrIZMqqJ-Td7E2LFUi6rekPDZRNPT2zAuE-X0bhjMjPRwOk6Po3d0h30f6dba5bj068QtwQ8PdHf_I4OEfvSNn_04UD_QbZx8GmZ0_9tYDE2CO_oF166Zx3Ci1z6iifiWvGpNH_Hd33hBvt_sv-0-ZYf727vd9pBZUDXPJCskYxysgqS0cqxqoLVKlcq0kiFaB6V0pUBbWtc2RghetEwUddEwp5gRF-TDee8UxqcF46y7cQlDOqmhkqouq0ryhOJnlA1jjAFbPQV_NOGkgenVW93p1Vu9equB6-RtIl2eSZj0__IYdLQeB4vOB7SzdqP_P_3qGd32fvDW9D_xhPGfTB25Zvrr-rz1dyAFh6Lm4g9v-ZZs</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Eastman, Jacqueline J., MD</creator><creator>Cavagnero, Kellen J., B.S</creator><creator>Deconde, Adam S., MD</creator><creator>Kim, Alexander S., MD</creator><creator>Broide, David H., MB, ChB, FAAAAI</creator><creator>Zuraw, Bruce L., MD</creator><creator>White, Andrew A., MD, FAAAAI</creator><creator>Christiansen, Sandra C., MD, FAAAAI</creator><creator>Doherty, Taylor Alan, MD, FAAAAI</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20170201</creationdate><title>Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease</title><author>Eastman, Jacqueline J., MD ; Cavagnero, Kellen J., B.S ; Deconde, Adam S., MD ; Kim, Alexander S., MD ; Broide, David H., MB, ChB, FAAAAI ; Zuraw, Bruce L., MD ; White, Andrew A., MD, FAAAAI ; Christiansen, Sandra C., MD, FAAAAI ; Doherty, Taylor Alan, MD, FAAAAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1792-60460021c713898d08b1fc7757af60eecd156d53ec5cdfba3324f03494b0d70a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Allergy and Immunology</topic><topic>Respiratory diseases</topic><topic>T cell receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eastman, Jacqueline J., MD</creatorcontrib><creatorcontrib>Cavagnero, Kellen J., B.S</creatorcontrib><creatorcontrib>Deconde, Adam S., MD</creatorcontrib><creatorcontrib>Kim, Alexander S., MD</creatorcontrib><creatorcontrib>Broide, David H., MB, ChB, FAAAAI</creatorcontrib><creatorcontrib>Zuraw, Bruce L., MD</creatorcontrib><creatorcontrib>White, Andrew A., MD, FAAAAI</creatorcontrib><creatorcontrib>Christiansen, Sandra C., MD, FAAAAI</creatorcontrib><creatorcontrib>Doherty, Taylor Alan, MD, FAAAAI</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eastman, Jacqueline J., MD</au><au>Cavagnero, Kellen J., B.S</au><au>Deconde, Adam S., MD</au><au>Kim, Alexander S., MD</au><au>Broide, David H., MB, ChB, FAAAAI</au><au>Zuraw, Bruce L., MD</au><au>White, Andrew A., MD, FAAAAI</au><au>Christiansen, Sandra C., MD, FAAAAI</au><au>Doherty, Taylor Alan, MD, FAAAAI</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>139</volume><issue>2</issue><spage>AB194</spage><epage>AB194</epage><pages>AB194-AB194</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD.</abstract><cop>St. Louis</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jaci.2016.12.631</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB194-AB194 |
issn | 0091-6749 1097-6825 |
language | eng |
recordid | cdi_proquest_journals_1867958862 |
source | ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals |
subjects | Allergy and Immunology Respiratory diseases T cell receptors |
title | Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A23%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nasal%20Group%202%20Innate%20Lymphoid%20Cells%20Accumulate%20during%20COX-1%20Inhibition%20in%20Aspirin-%20Exacerbated%20Respiratory%20Disease&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Eastman,%20Jacqueline%20J.,%20MD&rft.date=2017-02-01&rft.volume=139&rft.issue=2&rft.spage=AB194&rft.epage=AB194&rft.pages=AB194-AB194&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2016.12.631&rft_dat=%3Cproquest_cross%3E4313584041%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1867958862&rft_id=info:pmid/&rft_els_id=S0091674916321492&rfr_iscdi=true |